MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Escoubas, P.
Right arrow Articles by Lazdunski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Escoubas, P.
Right arrow Articles by Lazdunski, M.

Vol. 62, Issue 1, 48-57, July 2002

Novel Tarantula Toxins for Subtypes of Voltage-Dependent Potassium Channels in the Kv2 and Kv4 Subfamilies

Pierre Escoubas, Sylvie Diochot, Marie-Louise Célérier, Terumi Nakajima, and Michel Lazdunski

Institut de Pharmacologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique-Unité Mixte Recherche 6097, Sophia-Antipolis, Valbonne, France (P.E., S.D., M.L.); Université Pierre et Marie Curie, Paris, France (P.E., M.-L.C.); and Suntory Institute for Bioorganic Research, Osaka, Japan (T.N.)

Three novel peptides with the ability to inhibit voltage-dependent potassium channels in the shab (Kv2) and shal (Kv4) subfamilies were identified from the venom of the African tarantulas Stromatopelma calceata (ScTx1) and Heteroscodra maculata (HmTx1, HmTx2). The three toxins are 34- to 38-amino acid peptides that belong to the structural family of inhibitor cystine knot spider peptides reticulated by three disulfide bridges. Electrophysiological recordings in COS cells show that these toxins act as gating modifier of voltage-dependent K+ channels. ScTx1 is the first high-affinity inhibitor of the Kv2.2 channel subtype (IC50, 21.4 nM) to be described. ScTx1 also inhibits the Kv2.1 channels, with an IC50 of 12.7 nM, and Kv2.1/Kv9.3 heteromultimers that have been proposed to be involved in O2 sensing in pulmonary artery myocytes. In addition, it is the most effective inhibitor of Kv4.2 channels described thus far, with an IC50 of 1.2 nM. HmTx toxins share sequence similarities with both the potassium channel blocker toxins (HmTx1) and the calcium channel blocker toxin omega -GsTx SIA (HmTx2). They inhibit potassium current associated with Kv2 subtypes in the 100 to 300 nM concentration range. HmTx2 seems to be a specific inhibitor of Kv2 channels, whereas HmTx1 also inhibits Kv4 channels, including Kv4.1, with the same potency. HmTx1 is the first described peptide effector of the Kv4.1 subtype. Those novel toxins are new tools for the investigation of the physiological role of the different potassium channel subunits in cellular physiology.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Physiol.Home page
J. Johnston, S. J. Griffin, C. Baker, A. Skrzypiec, T. Chernova, and I. D. Forsythe
Initial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neurons
J. Physiol., July 15, 2008; 586(14): 3493 - 3509.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. Guan, T. Tkatch, D. J. Surmeier, W. E. Armstrong, and R. C. Foehring
Kv2 subunits underlie slowly inactivating potassium current in rat neocortical pyramidal neurons
J. Physiol., June 15, 2007; 581(3): 941 - 960.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
M. Nishizawa and K. Nishizawa
Molecular Dynamics Simulations of a Stretch-Activated Channel Inhibitor GsMTx4 with Lipid Membranes: Two Binding Modes and Effects of Lipid Structure
Biophys. J., June 15, 2007; 92(12): 4233 - 4243.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
G. C. Amberg and L. F. Santana
Kv2 channels oppose myogenic constriction of rat cerebral arteries
Am J Physiol Cell Physiol, August 1, 2006; 291(2): C348 - C356.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. T. Chen, K. D. Luykenaar, E. J. Walsh, M. P. Walsh, and W. C. Cole
Key Role of Kv1 Channels in Vasoregulation
Circ. Res., July 7, 2006; 99(1): 53 - 60.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. Herrington, Y.-P. Zhou, R. M. Bugianesi, P. M. Dulski, Y. Feng, V. A. Warren, M. M. Smith, M. G. Kohler, V. M. Garsky, M. Sanchez, et al.
Blockers of the Delayed-Rectifier Potassium Current in Pancreatic {beta}-Cells Enhance Glucose-Dependent Insulin Secretion.
Diabetes, April 1, 2006; 55(4): 1034 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
F. Bosmans, L. Rash, S. Zhu, S. Diochot, M. Lazdunski, P. Escoubas, and J. Tytgat
Four Novel Tarantula Toxins as Selective Modulators of Voltage-Gated Sodium Channel Subtypes
Mol. Pharmacol., February 1, 2006; 69(2): 419 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. Liu, D. R. Hansen, I. Kim, and T. A. Gilbertson
Expression and characterization of delayed rectifying K+ channels in anterior rat taste buds
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C868 - C880.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
B. Chagot, P. Escoubas, E. Villegas, C. Bernard, G. Ferrat, G. Corzo, M. Lazdunski, and H. Darbon
Solution structure of Phrixotoxin 1, a specific peptide inhibitor of Kv4 potassium channels from the venom of the theraphosid spider Phrixotrichus auratus
Protein Sci., May 1, 2004; 13(5): 1197 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
P. Escoubas, C. Bernard, G. Lambeau, M. Lazdunski, and H. Darbon
Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels
Protein Sci., July 1, 2003; 12(7): 1332 - 1343.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics